Terms: = Cervical cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
12 results:
1. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract] [Full Text] [Related]
2. Kaposi sarcoma at the base of the tongue in a renal transplant patient.
Safia A; Farhat R; Avraham Y; Merchavy S
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882263
[TBL] [Abstract] [Full Text] [Related]
3. Mechanistic analysis of endothelial lipase G promotion of the occurrence and development of cervical carcinoma by activating the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B/mechanistic target of rapamycin kinase signalling pathway.
Huang J; Liu R; Zhang Y; Sheng X
J Obstet Gynaecol; 2023 Dec; 43(1):2151353. PubMed ID: 36606668
[TBL] [Abstract] [Full Text] [Related]
4. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
Razavi H; Katanforosh A
BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
[TBL] [Abstract] [Full Text] [Related]
5. The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets.
Deng ZM; Chen GH; Dai FF; Liu SY; Yang DY; Bao AY; Cheng YX
PLoS One; 2022; 17(4):e0267108. PubMed ID: 35486636
[TBL] [Abstract] [Full Text] [Related]
6. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
[TBL] [Abstract] [Full Text] [Related]
7. Tuberous sclerosis complex misdiagnosed as multiple metastases in a cervical cancer patient: case report and literature review.
Ye T; Feng L; Peng M; Yuan S; Chen Y; Liu X; Chen J
Ann Palliat Med; 2021 Oct; 10(10):11232-11238. PubMed ID: 34763482
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
Zhu R; Wu H; Chen B; Pang J; Huo Z
Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mtor signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract] [Full Text] [Related]
10. Tocotrienols: The promising analogues of vitamin E for cancer therapeutics.
Sailo BL; Banik K; Padmavathi G; Javadi M; Bordoloi D; Kunnumakkara AB
Pharmacol Res; 2018 Apr; 130():259-272. PubMed ID: 29496592
[TBL] [Abstract] [Full Text] [Related]
11. cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract] [Full Text] [Related]
12. Progression of naive intraepithelial neoplasia genome to aggressive squamous cell carcinoma genome of uterine cervix.
Jung SH; Choi YJ; Kim MS; Baek IP; Lee SH; Lee AW; Hur SY; Kim TM; Lee SH; Chung YJ
Oncotarget; 2015 Feb; 6(6):4385-93. PubMed ID: 25738363
[TBL] [Abstract] [Full Text] [Related]
